Skip to main content
European Commission logo
español español
CORDIS - Resultados de investigaciones de la UE
CORDIS

A fully integrated, animal-free, end-to-end modelling approach to oral drug product development

Resultado final

Publicaciones

Exploring the Cocrystal Landscape of Posaconazole by Combining High-Throughput Screening Experimentation with Computational Chemistry

Autores: Matteo Guidetti, Rolf Hilfiker, Martin Kuentz, Annette Bauer-Brandl, Fritz Blatter
Publicado en: Crystal Growth & Design, Edición 23, 2, 2022, Página(s) 842-852, ISSN 1528-7483
Editor: American Chemical Society
DOI: 10.1021/acs.cgd.2c01072

Polymer-embedded deep eutectic solvents (PEDES) as a novel bio-enabling formulation approach

Autores: Shaida Panbachi , Josef Beranek, Martin Kuentz
Publicado en: European Journal of Pharmaceutical Sciences, Edición Volume 186, 1 July 2023, 2023, ISSN 0928-0987
Editor: Elsevier BV
DOI: 10.1016/j.ejps.2023.106463

Projection of Target Drug Particle Size in Oral Formulations Using the Refined Developability Classification System (rDCS)

Autores: Kristian Beran; Eline Hermans; René Holm; Kia Sepassi; Jennifer Dressman
Publicado en: Pharmaceutics; Volume 15; Edición 7; Pages: 1909, Edición 1, 2023, ISSN 1999-4923
Editor: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/pharmaceutics15071909

Microdialysis and nanofiltration allow to distinguish molecularly dissolved from colloid-associated drug concentrations during biomimetic dissolution testing of supersaturating formulations

Autores: Florentin Lukas Holzem, Jeannine Petrig Schaffland, Martin Brandl, Annette Bauer-Brandl, Cordula Stillhart
Publicado en: European Journal of Pharmaceutical Sciences, Edición Volume 174, 1 July 2022, 2022, ISSN 0928-0987
Editor: Elsevier BV
DOI: 10.1016/j.ejps.2022.106166

Biopredictive capability assessment of two dissolution/permeation assays, µFLUXTM and PermeaLoopTM, using supersaturating formulations of Posaconazole

Autores: Florentin Lukas Holzem, Anika Weck, Jeannine Petrig Schaffland, Cordula Stillhart, Sandra Klein, Annette Bauer-Brandl, Martin Brandl
Publicado en: European Journal of Pharmaceutical Sciences, Edición 176, 2022, Página(s) 106260, ISSN 0928-0987
Editor: Elsevier BV
DOI: 10.1016/j.ejps.2022.106260

Buscando datos de OpenAIRE...

Se ha producido un error en la búsqueda de datos de OpenAIRE

No hay resultados disponibles